Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease

Table 2 Helicobacter pylori eradication rates

	MOX-ST	CLA-ST	P value
ITT analysis
Eradication rate	91.3% (73/80)	71.6% (58/81)	0.014
95%CI	86.2%-95.4%	65.8%-77.4%
PP analysis
Eradication rate	93.6% (73/78)	75.3% (58/77)	0.022
95%CI	89.1%-98.1%	69.4%-81.8%

ITT: Intention-to-treat; PP: Per-protocol; CI: Confidence interval; MOX-ST: 14-d moxifloxacin-based sequential therapy; CLA-ST: 14-d clarithromycin-based sequential therapy.